After the United States Supreme Court ruling in the Association for Molecular Pathology v. Myriad Genetics in June of 2013, the industry scurried. The Court ruled that naturally occurring DNA is not patent eligible even if isolated, but cDNA or “complementary DNA” is because it is not naturally occurring but rather a product of the laboratory scientist…

Read More

Over the last decade we have succeeded in making GenomeQuest the industry standard for biological sequence searching in IP. We did this through the combination of specialized IP search algorithms and what has become the world’s largest IP sequence database (let alone the largest sequence database on earth) through a combination of automation and manual…

Read More